Global Cancer Diagnostics Market Size & Outlook, 2024-2030
Global cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Global cancer diagnostics market highlights
- The global cancer diagnostics market generated a revenue of USD 109,608.6 million in 2024 and is expected to reach USD 155,068.9 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 6.1% by 2030.
- In terms of segment, public insurance accounted for a revenue of USD 70,037.9 million in 2024.
- Public insurance is the most lucrative coverage segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Japan is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 109,608.6 million |
| Market revenue in 2030 | USD 155,068.9 million |
| Growth rate | 6.1% (CAGR from 2025 to 2030) |
| Largest segment | Public insurance |
| Fastest growing segment | Public insurance |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Public insurance, Private |
Other key industry trends
- In terms of revenue, the North America accounted for 41.2% of the global cancer diagnostics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Japan is the fastest growing regional market and is projected to reach USD 3,303.2 million by 2030.
Public insurance was the largest segment with a revenue share of 63.9% in 2024. Horizon Databook has segmented the Global cancer diagnostics market based on public insurance, private covering the revenue growth of each sub-segment from 2018 to 2030.
The global rise in the prevalence of cancer is one of the major factors facilitating market growth in the recent past. According to WHO, the global cancer burden was estimated to be about 18.1 million new cases and nearly 43.8 million deaths in 2018. It is also indicated that one in six women and one in five men are likely to develop cancer at some point in their lives.
In addition, the number of individuals within the 5-year prevalence is expected to be about 43.8 million. The rise in the number of cancer cases can be majorly attributed to various factors such as the rising geriatric population, increasing population, and changing prevalence of certain causes of cancer associated with economic & social development.
This is particularly seen in emerging economies, wherein a general shift is observed in terms of cancers associated with poverty, which is a contrast to developed economies, wherein cancer cases have increasingly been associated with lifestyle disorders. According to the WHO, obesity, certain types of infections, and radiation exposure are major factors associated with the increase in the number of cancer cases.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global cancer diagnostics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Cancer diagnostics market size, 2024 (US$M)
Global cancer diagnostics market share, by coverage, 2024 & 2030 (%, US$M)
Cancer diagnostics market: Opportunity assessment by country
Global cancer diagnostics market, by region, 2024 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
